Literature DB >> 6379849

The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases.

J Myren, I A Bouchier, G Watkinson, A Softley, S E Clamp, F T de Dombal.   

Abstract

This presentation describes the progress during 1978-1982 of the O.M.G.E. Multinational Survey of patients with inflammatory bowel disease. After a brief description of the study design and protocol, and review of results up to 1978, the status of the survey in 1982 is presented. In all, 35 centres contributed 2,657 cases at that time; data collection being meticulous via previously designed proformata. Diagnostic criteria are next discussed. Little change between 1978 and 1982 is noted, with wide variation in the UC/CD ratio for individual centres, but continuing evidence of a congruence of diagnostic thought, now codified into a simple (and recommended) O.M.G.E. Scoring System. Patients seen prior to 1978 were reviewed in 1982. Where attempted, a follow-up of over 90% was achieved, usually more than four years after the original presentation. Interesting data resulted. The stability of diagnosis was high, only 3.4% of patient diagnoses changing between 1978 and 1982. The mortality of Crohn's disease patients, usually unrelated to surgery, was higher than that of ulcerative colitis patents, and the cancer risk identical in the two groups. Most patients were well at review; but--though asymptomatic--were usually on prophylactice therapy, most commonly with salazopyrine. Finally, problems in assessing severity and activity of disease are discussed, and joint studies between O.M.G.W. and the newly formed International Organisation for the Study of I.B.D. described. As regards Crohn's disease, several 'indices of activity' already exist; when tested on a set of 200 O.M.G.E. patients, indices did not correlate well with each other, or with patient prognosis. Further studies are suggested during 1982-1986.

Entities:  

Mesh:

Year:  1984        PMID: 6379849

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  25 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Increased circulating concentrations of growth-related oncogene (GRO)-alpha in patients with inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Osamu Tsuruta; Nobuo Tomiyasu; Kosuke Takaki; Asuka Suzuki; Junya Masuda; Hiroshi Yamasaki; Atsushi Toyonaga; Michio Sata
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease.

Authors:  K Mitsuyama; N Tomiyasu; A Suzuki; K Takaki; H Takedatsu; J Masuda; H Yamasaki; S Matsumoto; O Tsuruta; A Toyonaga; M Sata
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

4.  Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease.

Authors:  Moriaki Hatsugai; Manae S Kurokawa; Takefumi Kouro; Kohei Nagai; Mitsumi Arito; Kayo Masuko; Naoya Suematsu; Kazuki Okamoto; Fumio Itoh; Tomohiro Kato
Journal:  J Gastroenterol       Date:  2010-01-05       Impact factor: 7.527

5.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

6.  IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease.

Authors:  F T de Dombal; A Softley
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

7.  Back to the future; or forward to the past?

Authors:  F T de Dombal
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

8.  Clinical activity assessment in inflammatory bowel disease.

Authors:  J W Singleton
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

9.  Circulating cytokines reflect mucosal inflammatory status in patients with Crohn's disease.

Authors:  Farid Ljuca; Adnan Gegic; Nermin N Salkic; Nada Pavlovic-Calic
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

10.  Clinical course and long-term prognosis of Japanese patients with ulcerative colitis.

Authors:  N Hiwatashi; H Yamazaki; M Kimura; T Morimoto; H Watanabe; T Toyota
Journal:  Gastroenterol Jpn       Date:  1991-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.